Protagonist Therapeutics Inc (PTGX)
Cost of Revenue
$407.00K
TTM · Period ending: · USD
PTGX Cost of Revenue
Latest reported$407.00Kperiod ending
Latest reported$407.00Kperiod ending
PTGX TTM Cost of Revenue ($0.00 → $407.00K)
TTM cost of revenue
High-resolution chart · PNG
PTGX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 407,000 | |
| 407,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 843,000 | |
| 1,676,000 | |
| 2,495,000 | |
| 2,495,000 | |
| 1,652,000 | |
| 819,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 2,774,000 | |
| 2,774,000 | |
| 2,774,000 | |
| 2,774,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |